Propanc Biopharma, Inc. (PPCB)
OTCMKTS
· Delayed Price · Currency is USD
5.25
-0.25 (-4.55%)
Apr 4, 2025, 2:39 PM EST
Propanc Biopharma Statistics
Total Valuation
PPCB has a market cap or net worth of 80,703. The enterprise value is 1.28 million.
Market Cap | 80,703 |
Enterprise Value | 1.28M |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PPCB has 15,372 shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 15,372 |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.02% |
Owned by Institutions (%) | 0.08% |
Float | 15,369 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.68 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
Current Ratio | 0.00 |
Quick Ratio | 0.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.77 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -462.23% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 29.07% |
Revenue Per Employee | n/a |
Profits Per Employee | -931,366 |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +114,030.44% in the last 52 weeks. The beta is 17,240.95, so PPCB's price volatility has been higher than the market average.
Beta (5Y) | 17,240.95 |
52-Week Price Change | +114,030.44% |
50-Day Moving Average | 7.13 |
200-Day Moving Average | 1.78 |
Relative Strength Index (RSI) | 41.02 |
Average Volume (20 Days) | 166 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.40 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.18M |
Pretax Income | -1.67M |
Net Income | -1.86M |
EBITDA | -1.18M |
EBIT | -1.18M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 14,633 in cash and 1.21 million in debt, giving a net cash position of -1.19 million or -77.70 per share.
Cash & Cash Equivalents | 14,633 |
Total Debt | 1.21M |
Net Cash | -1.19M |
Net Cash Per Share | -77.70 |
Equity (Book Value) | -4.16M |
Book Value Per Share | -286.65 |
Working Capital | -4.14M |
Cash Flow
Operating Cash Flow | -604,562 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PPCB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -2,308.13% |
FCF Yield | n/a |
Stock Splits
The last stock split was on January 29, 2025. It was a reverse split with a ratio of 0.0000167.
Last Split Date | Jan 29, 2025 |
Split Type | Reverse |
Split Ratio | 0.0000167 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |